Very-Low-Density Lipoprotein–Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-III

BACKGROUND: Routine apolipoprotein (apo) measurements for cardiovascular disease (CVD) are restricted to apoA-I and apoB. Here, the authors measured an unprecedented range of apolipoproteins in a prospective, population-based study and relate their plasma levels to risk of CVD. OBJECTIVES: This stud...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Am Coll Cardiol
Autors principals: Pechlaner, Raimund, Tsimikas, Sotirios, Yin, Xiaoke, Willeit, Peter, Baig, Ferheen, Santer, Peter, Oberhollenzer, Friedrich, Egger, Georg, Witztum, Joseph L., Alexander, Veronica J., Willeit, Johann, Kiechl, Stefan, Mayr, Manuel
Format: Artigo
Idioma:Inglês
Publicat: Elsevier Biomedical 2017
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5314136/
https://ncbi.nlm.nih.gov/pubmed/28209220
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2016.11.065
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars